The D-day. The role of vitamin D in the prevention and the additional therapy of cancers;A D-nap. A D-vitamin helye a daganatprevencióban és a kiegészíto kezelésben

Magyar Onkologia

Volumn 54, Issue 4, 2010, Pages 303-314

  Speer, Gábor ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

colorectal cancer; CYP24A1; tumorigenesis; vitamin D

Indexed keywords

OXYGENASE; VITAMIN D; VITAMIN D DERIVATIVE;

ADJUVANT THERAPY; BREAST CANCER; CANCER CELL; CANCER PREVENTION; CANCER THERAPY; CANCER TISSUE; CARCINOGENESIS; COLORECTAL CANCER; ENZYME SYNTHESIS; HUMAN; HUNGARY; IN VITRO STUDY; IN VIVO STUDY; METABOLITE; PROGNOSIS; PROSTATE CANCER; PROTEIN EXPRESSION; REVIEW; SUN EXPOSURE; THERAPY EFFECT; VITAMIN D DEFICIENCY;

BREAST NEOPLASMS; CARCINOMA, HEPATOCELLULAR; CLINICAL TRIALS AS TOPIC; COLONIC NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; HUNGARY; LIVER NEOPLASMS; MALE; NEOPLASMS; PROGNOSIS; PROSTATIC NEOPLASMS; RECEPTORS, CALCITRIOL; STEROID HYDROXYLASES; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 79951904077     PISSN: 00250244     EISSN: 20600399     Source Type: Journal    
DOI: 10.1556/MOnkol.54.2010.4.4     Document Type: Review

References (43)

1. Abe E, Miyaura C, Sakagami H, et al. Differentiation of mouse myeloid leukemia cells induced by 1 alpha,25-dihydroxyvitamin D3. Proc Natl Acad Sci USA 78:4990-4994, 1981 (Pubitemid 12225607)
2. Albertson DG, Ylstra B, Segraves R, et al. Quantitative mapping of amplicon structure by array CGH identifies CYP24 as a candidate oncogene. Nat Genet 25:144-146, 2000 (Pubitemid 30394982)
3. Baran DT, Quail JM, Ray R, et al. Annexin II is the membrane receptor that mediates the rapid actions of 1alpha,25-dihydroxyvitamin D(3). J Cell Biochem 78:34-46, 2000 (Pubitemid 30346381)
4. Bhattoa HP, Bettembuk P, Ganacharya S, et al. Prevalence and seasonal variation of hypovitaminosis D and its relationship to bone metabolism in community dwelling postmenopausal Hungarian women. Osteoporos Int 15:447-451, 2004 (Pubitemid 38843172)
5. Bises G, Kallay E, Weiland T, et al. 25-hydroxyvitamin D3-1alpha-hydroxylase expression in normal and malignant human colon. J Histochem Cytochem 52:985-989, 2004 (Pubitemid 38857163)
6. Brown AJ, Dusso A, Slatopolsky E. Vitamin D. Am J Physiol 277: F157-175, 1995
7. Chen KS, DeLuca HF. Cloning of the human 1 alpha,25-dihydroxyvitamin D-3 24-hydroxylase gene promoter and identification of two vitamin D-responsive elements. Biochim Biophys Acta 1263:1-9, 1995
8. Cordero JB, Cozzolino M, Lu Y, et al. 1,25-Dihydroxyvitamin D down-regulates cell membrane growth- and nuclear growth-promoting signals by the epidermal growth factor receptor. J Biol Chem 277:38965-38971, 2002 (Pubitemid 35154762)
9. Cozzolino M, Lu Y, Finch J, et al. p21WAF1 and TGF-alpha mediate parathyroid growth arrest by vitamin D and high calcium. Kidney Int 60:2109-2117, 2001 (Pubitemid 33070454)
10. Darwish HM, DeLuca HF. Analysis of binding of the 1,25-dihydroxyvitamin D3 receptor to positive and negative vitamin D response elements. Arch Biochem Biophys 334:223-234, 1996 (Pubitemid 26347304)
11. Deeb KK, Trump DL, Johnson CS. Vitamin D signalling pathways in cancer: potential for anticancer therapeutics. Nat Rev Cancer 7:684-700, 2007 (Pubitemid 47327412)
12. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 61:759-767, 1990
13. Ferlay J, Autier P, Boniol M, et al. Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 18:581-592, 2007
14. Garland CF, Garland FC. Do sunlight and vitamin D reduce the likelihood of colon cancer? Int J Epidemiol 9:227-231, 1980
15. Garland FC, Garland CF, Gorham ED, et al. Geographic variation in breast cancer mortality in the United States: a hypothesis involving exposure to solar radiation. Prev Med 19:614-622, 1990
16. Hanchette CL, Schwartz GG. Geographic patterns of prostate cancer mortality. Evidence for a protective effect of ultraviolet radiation. Cancer 70:2861-2869, 1990
17. Haussler MR, Whitfield GK, Haussler CA, et al. The nuclear vitamin D receptor: biological and molecular regulatory properties revealed. J Bone Miner Res 13:325-349, 1998 (Pubitemid 28146215)
18. Hewison M, Zehnder D, Chakraverty R, et al. Vitamin D and barrier function: a novel role for extra-renal 1 alpha-hydroxylase. Mol Cell Endocrinol 215:31-38, 2004 (Pubitemid 38333240)
19. Horváth HC, Lakatos P, Kósa JP, et al. The candidate oncogene CYP24A1: A potential biomarker for colorectal tumorigenesis. J Histochem Cytochem 58:277-285, 2010
20. 3 in colorectal cancer. J Steroid Biochem Mol Biol, e-pub, 2010
21. King AN, Beer DG, Christensen PJ, et al. The vitamin D/CYP24A1 story in cancer. Anticancer Agents Med Chem 10:213-224, 2010
22. Korn WM, Yasutake T, Kuo WL, et al. Chromosome arm 20q gains and other genomic alterations in colorectal cancer metastatic to liver, as analyzed by comparative genomic hybridization and fluorescence in situ hybridization. Genes Chromosomes Cancer 25:82-90, 1999 (Pubitemid 29226589)
23. Kumamoto T, Ito A, Omura T. Critical region in the extension peptide for the import of cytochrome P-450(SCC) precursor into mitochondria. J Biochem 105:72-78, 1989 (Pubitemid 19036172)
24. Lakatos P, Speer G. A D-vitamin biológiai és klinikai hatásai. Lege Artis Medicinae 12:8-17, 2002
25. Leong GM, Subramaniam N, Issa LL, et al. Ski-interacting protein, a bifunctional nuclear receptor coregulator that interacts with NCoR/ SMRT and p300. Biochem Biophys Res Commun 315:1070-1076, 2004 (Pubitemid 38249412)
26. Liu W, Yu WR, Carling T, et al. Regulation of gp330/megalin expression by vitamins A and D. Eur J Clin Invest 28:100-107, 1998 (Pubitemid 28085809)
27. Ly LH, Zhao XY, Holloway L, et al. Liarozole acts synergistically with 1alpha,25-dihydroxyvitamin D3 to inhibit growth of DU 145 human prostate cancer cells by blocking 24-hydroxylase activity. Endocrinology 140:2071-2076, 1999 (Pubitemid 30636444)
28. Mimori K, Tanaka Y, Yoshinaga K, et al. Clinical significance of the overexpression of the candidate oncogene CYP24 in esophageal cancer. Ann Oncol 15:236-241, 2004 (Pubitemid 38262621)
29. Moan J, Porojnicu AC, Robsahm TE, et al. Solar radiation, vitamin D and survival rate of colon cancer in Norway. J Photochem Photobiol B 78:189-193, 2005 (Pubitemid 40220986)
30. Morimoto S, Kumahara Y. A patient with psoriasis cured by 1 alpha-hydroxyvitamin D3. Med J Osaka Univ 35:51-54, 1985
31. Nemere I, Farach-Carson MC, Rohe B, et al. Ribozyme knockdown functionally links a 1,25(OH)2D3 membrane binding protein (1,25D3-MARRS) and phosphate uptake in intestinal cells. Proc Natl Acad Sci USA 101:7392-7397, 2004
32. Niv Y, Sperber AD, Figer A, et al. In colorectal carcinoma patients, serum vitamin D levels vary according to stage of the carcinoma. Cancer 86:391-397, 1999
33. Ou WJ, Ito A, Morohashi K, et al. Processing-independent in vitro translocation of cytochrome P-450(SCC) precursor across mitochondrial membranes. J Biochem 100:1287-1296, 1986
34. Rachez C, Freedman LP. Mechanisms of gene regulation by vitamin D(3) receptor: a network of coactivator interactions. Gene 246:9-21, 2000 (Pubitemid 30190157)
35. Ren S, Nguyen L, Wu S, et al. Alternative splicing of vitamin D-24-hydroxylase: a novel mechanism for the regulation of extrarenal 1,25- dihydroxyvitamin D synthesis. J Biol Chem 280:20604-20611, 2005 (Pubitemid 40776763)
36. Schlegel J, Stumm G, Scherthan H, et al. Comparative genomic in situ hybridization of colon carcinomas with replication error. Cancer Res 55:6002-6005, 1995
37. Schwartz GG, Whitlatch LW, Chen TC, et al. Human prostate cells synthesize 1,25-dihydroxyvitamin D3 from 25-hydroxyvitamin D3. Cancer Epidemiol Biomarkers Prev 7:391-395, 1998 (Pubitemid 28354127)
38. Speer G. A hazai D-vitamin-hiány okai és következményei: ideje felszámolni. Háziorvosi Továbbképzocombining double acute accent Szemle 10:760-763, 2005
39. Speer G, Lakatos P. D-vitamin és kalcium szerepe a tumorgenezis gátlásában. Ca és Csont 3:53-56, 2000
40. Tan J, Dwivedi PP, Anderson P, et al. Antineoplastic agents target the 25-hydroxyvitamin D3 24-hydroxylase messenger RNA for degradation: implications in anticancer activity. Mol Cancer Ther 6:3131-3138, 2007
41. Tangrea J, Helzlsouer K, Pietinen P, et al. Serum levels of vitamin D metabolites and the subsequent risk of colon and rectal cancer in Finnish men. Cancer Causes Control 8:615-625, 1997 (Pubitemid 27330494)
42. Weiss MM, Snijders AM, Kuipers EJ, et al. Determination of amplicon boundaries at 20q13.2 in tissue samples of human gastric adenocarcinomas by high-resolution microarray comparative genomic hybridization. J Pathol 200:320-326, 2003 (Pubitemid 36827306)
43. Zatonski W, Didkowska J. Closing the gap: cancer in Central and Eastern Europe (CEE). Eur J Cancer 44:1425-1437, 2008